On February 1st, 2019 from 2:00 p.m. to 5:30 p.m., at the Campus of Humanitas University, an educational meeting...
Interventional Cardiologist at Humanitas Research Hospital
Academic Background and Education
Dr Stefanini was born in Rome, where he studied Medicine and finalized his training in Cardiology at Sapienza University.
In 2010 he moved to Bern University Hospital for a clinical research fellowship supported by a grant of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). In 2012 he was awarded a competitive 3-year research support under the Special Program University Medicine program (SPUM) of the Swiss National Science Foundation, supporting his position researcher and interventional cardiologist at Bern University Hospital.
In 2015, Dr Stefanini moved to Milan where he currently working as interventional cardiologist at Humanitas Research Hospital and has an appointment as Assistant Professor in Cardiology at Humanitas University.
He is currently following an Executive MSc in Health Economics, Outcomes and Management in Cardiovascular Sciences at the London School of Economics (LSE) supported by a scholarship of the European Society of Cardiology (ESC).
Scientific and Research Interests
Dr Stefanini’s main research area is minimally-invasive treatment strategies for coronary artery disease, with a specific focus on devices for coronary revascularization. He has been involved in the conduct, data-analysis, and successful publication of several randomized trials, observational studies, and meta-analyses.
He has authored several relevant articles in major medical journals including the New England Journal of Medicine and the Lancet. Dr Stefanini has completed a PhD in Experimental Medicine with a thesis on “Myocardial revascularization with drug-eluting coronary artery stents: the clinical impact of technological progress”.
He is actively contributing to the European Society of Cardiology (ESC), has been a member of the Task Force for the 2014 Guidelines on Myocardial Revascularization and is a member of the Task Force on the evaluation of coronary artery stents of the ESC and EAPCI.
- Stefanini GG, Holmes DR Jr. Drug-Eluting Coronary Artery Stents. N Eng J Med 2013; 368:254-65.
- Stefanini GG, et al. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. Lancet 2013, 382:1879-88
- Stefanini GG, et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet 2011; 378:1940-8.
- Siontis GC, Stefanini GG, et al. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet 2015; 386:655-64.
- Stefanini GG, et al. Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation. Eur Heart J 2014; 35:2530-40
- Stefanini GG, et al. Biodegradable Polymer Drug-Eluting Stents Reduce the Risk of Stent Thrombosis at 4 Years in Patients Undergoing Percutaneous Coronary Intervention. Eur Heart J 2012; 33:1214-22
Academic honors, awards and prizes
- Scholarship of the European Society of Cardiology (ESC) for an Executive MSc in Health Economics, Outcomes and Management in Cardiovascular Sciences 2016-2018 at the London School of Economics, London, UK
- William Harvey Award, Italian Society of Cardiology (SIC) 2014
- Best Abstract Award, 2014 Joint Annual Meeting of the Swiss Society of Cardiology (SGK-SSC)
- Fellow of the European Society of Cardiology (FESC) since 2014
- Finalist of the Linnemeier Spirit of Interventional Cardiology Young Investigator Award 2012, Transcatheter Cardiovascular Therapeutics (TCT), Cardiovascular Research Foundation
- Research Grant 2011, European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology (ESC)
- GISE Prize 2010 for best scientific contribution, 31st Congress of the Italian Society of Interventional Cardiology (SICI-GISE)